Skip to main content
Erschienen in: Pediatric Cardiology 2/2008

01.03.2008 | Original

Association of Vascular Endothelial Growth Factor C–634 G Polymorphism in Taiwanese Children With Kawasaki Disease

verfasst von: K.-C. Hsueh, Y.-J. Lin, J.-S. Chang, L. Wan, Y.-H. Tsai, C.-H. Tsai, C.-P. Chen, F.-J. Tsai

Erschienen in: Pediatric Cardiology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

High expression of circulating vascular endothelial growth factor (VEGF) has been reported in patients with Kawasaki disease (KD). In the pathophysiology of KD, VEGF is considered to be involved, especially in the development of coronary artery lesions. This study aimed to examine whether the VEGF-634 promoter polymorphism is a marker of KD susceptibility or severity in Chinese patients in Taiwan. The study included 93 KD patients and 96 normal control subjects. Genotype and allelic frequencies for the VEGF gene polymorphism in the two groups were compared. The number of individuals with the VEGF-634 G/G genotype was significantly greater among the patients with KD than among the healthy control subjects (p = 0.011). The odds ratio for the development of KD in individuals with the VEGF-634 G/G genotype was found to be 2.03 (95% confidence interval [CI], 1.14–3.63) compared with the VEGF-634 G/C and VEGF-634 C/C genotypes. No significant difference was observed in the genotype or allelic frequencies of VEGF C-634 G polymorphism between the patients with and those without coronary artery lesions. In conclusion, the results suggest that VEGF-634 G/G genotype may be involved in the development of KD in Taiwanese children.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. (2002) A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635–1639PubMedCrossRef Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. (2002) A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635–1639PubMedCrossRef
2.
Zurück zum Zitat Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P, et al. (2003) Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 30:2160–2164PubMed Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P, et al. (2003) Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 30:2160–2164PubMed
3.
Zurück zum Zitat Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, et al. (2006) Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 54:1588–1594PubMedCrossRef Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, et al. (2006) Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 54:1588–1594PubMedCrossRef
4.
Zurück zum Zitat Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV (1999) Novel polymorphisms in the promoter and 5′-UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60:1245–1249PubMedCrossRef Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV (1999) Novel polymorphisms in the promoter and 5′-UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60:1245–1249PubMedCrossRef
5.
Zurück zum Zitat Carmeliet P, Collen D (1998) Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int 53:1519–1549PubMedCrossRef Carmeliet P, Collen D (1998) Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int 53:1519–1549PubMedCrossRef
6.
Zurück zum Zitat Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimoto I, et al. (2001) Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 49:74–80PubMedCrossRef Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimoto I, et al. (2001) Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 49:74–80PubMedCrossRef
7.
Zurück zum Zitat Hirao J, Hibi S, Andoh T, Ichimura T (1997) High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112:150–156CrossRef Hirao J, Hibi S, Andoh T, Ichimura T (1997) High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112:150–156CrossRef
8.
Zurück zum Zitat Hirose S, Hamashima Y (1978) Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome: a skin biopsy study of 27 patients. Eur J Pediatr 129:17–27PubMedCrossRef Hirose S, Hamashima Y (1978) Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome: a skin biopsy study of 27 patients. Eur J Pediatr 129:17–27PubMedCrossRef
9.
Zurück zum Zitat Iijima K, Yoshikawa N, Connolly DT, Nakamura H (1993) Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959–966PubMedCrossRef Iijima K, Yoshikawa N, Connolly DT, Nakamura H (1993) Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959–966PubMedCrossRef
10.
Zurück zum Zitat Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959PubMedCrossRef Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959PubMedCrossRef
11.
Zurück zum Zitat Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614–7620PubMedCrossRef Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614–7620PubMedCrossRef
12.
Zurück zum Zitat Lin CY, Lin CC, Hwang B, Chiang BN (1991) The changes of interleukin-2, tumor necrotic factor, and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 150:179–182PubMedCrossRef Lin CY, Lin CC, Hwang B, Chiang BN (1991) The changes of interleukin-2, tumor necrotic factor, and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 150:179–182PubMedCrossRef
13.
Zurück zum Zitat Lin CY, Lin CC, Hwang B, Chiang BN (1993) Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 121:924–926 Lin CY, Lin CC, Hwang B, Chiang BN (1993) Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 121:924–926
14.
Zurück zum Zitat Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. (1998) Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 44:596–599PubMedCrossRef Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. (1998) Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 44:596–599PubMedCrossRef
15.
Zurück zum Zitat Maury CPJ, Salo E, Pelkonen P (1989) Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med 113:651–654PubMed Maury CPJ, Salo E, Pelkonen P (1989) Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med 113:651–654PubMed
16.
Zurück zum Zitat Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor and its receptors. FASEB J 13:9–22PubMed Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor and its receptors. FASEB J 13:9–22PubMed
17.
Zurück zum Zitat Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T (2000) Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 159:424–429PubMedCrossRef Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T (2000) Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 159:424–429PubMedCrossRef
18.
Zurück zum Zitat Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443–448PubMedCrossRef Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443–448PubMedCrossRef
19.
20.
Zurück zum Zitat Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, et al. (2004) Vascular endothelial growth factor gene polymorphisms in Behcet’s disease. J Rheumatol 31:1785–1789PubMed Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, et al. (2004) Vascular endothelial growth factor gene polymorphisms in Behcet’s disease. J Rheumatol 31:1785–1789PubMed
21.
Zurück zum Zitat Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. (2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260–264PubMed Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. (2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260–264PubMed
22.
Zurück zum Zitat Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812–816PubMed Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812–816PubMed
23.
Zurück zum Zitat Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C (2000) Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J 41:245–256PubMedCrossRef Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C (2000) Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J 41:245–256PubMedCrossRef
24.
Zurück zum Zitat Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y (1999) Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 83:337–339PubMedCrossRef Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y (1999) Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 83:337–339PubMedCrossRef
25.
Zurück zum Zitat Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603–607PubMed Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603–607PubMed
26.
Zurück zum Zitat Viac J, Pernet I, Schmitt D, Claudy A (1999) Overexpression of circulating vascular endothelial growth factor in leukocytoclastic vasculitis. Arch Dermatol Res 291:622–623PubMedCrossRef Viac J, Pernet I, Schmitt D, Claudy A (1999) Overexpression of circulating vascular endothelial growth factor in leukocytoclastic vasculitis. Arch Dermatol Res 291:622–623PubMedCrossRef
27.
Zurück zum Zitat Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD (2005) Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 24:998–1004PubMedCrossRef Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD (2005) Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 24:998–1004PubMedCrossRef
28.
Zurück zum Zitat Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232–1235PubMedCrossRef Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232–1235PubMedCrossRef
29.
Zurück zum Zitat Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC (1996) Peripheral mononuclear cells express VEGF and the VEGF receptor flt-1 (abstract). J Am Soc Nephrol 7:A2390 Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC (1996) Peripheral mononuclear cells express VEGF and the VEGF receptor flt-1 (abstract). J Am Soc Nephrol 7:A2390
Metadaten
Titel
Association of Vascular Endothelial Growth Factor C–634 G Polymorphism in Taiwanese Children With Kawasaki Disease
verfasst von
K.-C. Hsueh
Y.-J. Lin
J.-S. Chang
L. Wan
Y.-H. Tsai
C.-H. Tsai
C.-P. Chen
F.-J. Tsai
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 2/2008
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-007-9049-3

Weitere Artikel der Ausgabe 2/2008

Pediatric Cardiology 2/2008 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.